XML 14 R4.htm IDEA: XBRL DOCUMENT v3.22.2
Consolidated Condensed Statements of Income - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2022
Jun. 30, 2021
Income Statement [Abstract]        
Product revenues $ 260,715 $ 266,005 $ 528,372 $ 554,540
Type of Revenue [Extensible List] us-gaap:ProductMember us-gaap:ProductMember us-gaap:ProductMember us-gaap:ProductMember
Cost of sales $ 201,338 $ 186,792 $ 404,882 $ 387,658
Gross margin 59,377 79,213 123,490 166,882
Operating expenses:        
Net research and development expenses 19,325 18,227 39,759 35,830
Selling, general and administrative expenses 31,943 27,223 61,251 55,749
Restructuring expenses 374 2,091 555 2,882
Total operating expenses 51,642 47,541 101,565 94,461
Operating income 7,735 31,672 21,925 72,421
Interest expense, net (1,430) (630) (1,999) (1,669)
Foreign currency gain (loss) 4,552 (515) 6,769 258
Other income 134 12 338 3
Earnings before income tax 10,991 30,539 27,033 71,013
Income tax expense 3,919 5,748 8,214 13,313
Net income $ 7,072 $ 24,791 $ 18,819 $ 57,700
Basic earnings per share $ 0.21 $ 0.75 $ 0.57 $ 1.75
Diluted earnings per share $ 0.21 $ 0.74 $ 0.56 $ 1.72
Weighted average number of shares – basic 33,119,085 33,100,230 33,077,029 33,025,432
Weighted average number of shares – diluted 33,426,123 33,544,208 33,421,987 33,468,849